NEW YORK, May 12, 2010 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of drugs to fight biowarfare pathogens, today announced that its Chief Executive Officer, Dr. Eric Rose, spoke before the House Subcommittee on Labor, Health and Human Services, and Education Appropriations today to discuss the biodefense industry’s concerns that possible funding cuts to biodefense programs will hurt the development of medical countermeasures.
